AC |
Accession Number |
accession number of the mutated site |
ID |
Identifier |
{species acronym $ {gene acronym} |
DT |
Date |
creation date; author |
DT |
Date |
date of last update; updater |
SC |
Site Source |
g (DNA) or r (RNA) |
OS |
Species |
biological species (TRANSFAC®) |
OC |
Taxonomic Classification |
systematic biological classification of the species (TRANSFAC®) |
SO |
Factor Source |
link to cells/expression systems the binding factors were derived from; cell name |
DE |
Description |
link to TRANSFAC® Gene (via accession number); gene name |
RE |
Site Region |
functional region of the gene (e. g. promoter, enhancer, intron etc.) where the mutated site is located |
EL |
Element |
specific term for a particular site (e.g. estrogen response element, Sp1 site) |
WS |
Wildtype Site |
link to wildtype site (via accession number); wild type site identifier; gene name |
MS |
Mutated Sequence |
mutated sequence; either corresponding to the linked TRANSFAC® site sequence or a DNA stretch of >= 20 nucleotides (enclosing the mutation). When the authors emphasized a certain sequence motif within a sequence, it is written in capitals, while the rest of the sequence is shown in lowercase letters. |
SF |
First Position of Element |
first position of the mutated site bound by transription factor |
ST |
Last Position of Element |
last position of the mutated site bound by transription factor |
S1 |
Definition of First Position |
definition of position numbering (if not referring to the transcription start site) such as ATG or restriction sites |
BF |
Binding Factor |
link to binding wildtype factor (via accession number). The "Quality" of the factor-site interaction is indicated on a six-level scale ->; the alterations in "Binding" of the mutated factor to the wildtype site is indicated on a five-level scale -> |
CC |
Comment |
functional consequences of the mutation in the site are listed here, such as altered factor binding or promoter activity |
GT |
Genotype |
link to the Genotype -> table (via accession number) |
MM |
Methods |
method(s) applied for the identification/characterization of the mutated site |
DR |
External Databases |
link to external database (EMBL) (via accession number) |
RN |
Reference Number |
|
RX |
Reference MEDLINE ID |
|
RA |
Reference Author(s) |
|
RT |
Reference Title |
|
RL |
Reference Journal |
|
